Russia’s pharmaceutical company Zavod Medsintez, in partnership with Pakistan’s Genetics Pharmaceuticals Private Limited, plans a major investment in Pakistan’s healthcare sector. The total investment is estimated at around $80 million.
The project focuses on local Insulin production in Pakistan. Officials say this step may improve access to diabetes treatment and reduce reliance on imports.
According to sources, the investment will be completed in two phases. The goal is to build a full insulin manufacturing system in the country.
In the first phase, around $20 million will be invested. This amount will be used to establish an aseptic filling plant. The facility will handle bulk insulin imports and local filling operations.
Officials said this plant will improve the supply chain for Insulin products. The expected completion date for this phase is December 2028.
The second phase is more advanced. It includes a $60 million investment for an Active Pharmaceutical Ingredient (API) production plant.
This facility will support full-scale Insulin manufacturing. It will include technology transfer and biotechnology development. The production process will cover everything from API purification to final packaging.
The second phase is expected to be completed by December 2031. Once operational, it will significantly expand local pharmaceutical capacity.
Meanwhile, the Drug Regulatory Authority of Pakistan (DRAP) has approved marketing of several insulin products. These include Rosinsulin R, Rosinsulin C, and Rosinsulin M 30/70.
Officials said DRAP will closely monitor the project’s progress. The authority will require detailed reports and stage-wise updates from both companies.
The approval is seen as an important step for improving Insulin availability in Pakistan. It is also expected to support better treatment options for diabetic patients.
Experts say local production of Insulin could help reduce costs in the long run. It may also reduce pressure on imported medicines in the healthcare system.
The development also highlights growing cooperation between Pakistan and Russia in the pharmaceutical sector. Earlier, Russia approved seafood imports from Pakistan, opening new trade opportunities.
Federal Minister for Maritime Affairs Muhammad Junaid Anwar Chaudhry called the partnership a significant milestone. He said it could strengthen Pakistan’s export and industrial capacity.
In other related news also read Insulin, Key Medicines Prices Surge Sharply in KP
Overall, the Insulin production project is expected to improve medical access and support pharmaceutical growth in Pakistan over the coming years.
